New lung scans reveal how asthma drugs work inside the lungs

NCT ID NCT07426458

Recruiting now Knowledge-focused Sponsor: University of Miami Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study uses advanced lung imaging to see how two asthma medications—albuterol alone and albuterol combined with budesonide—change airflow and blood flow in the lungs. About 40 adults with asthma will undergo scans before and after taking the medications. The goal is to better understand how these drugs work at a detailed level, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Albuterol Sulfate and Albuterol-Budesonide
What this could lead to: If successful, this study could help doctors better understand how asthma medications work in the lungs, potentially leading to more personalized treatment.
What could go wrong: This is a small, early-phase imaging study, not a treatment trial. The findings may not directly change patient care or apply to all asthma patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA

Contacts and locations

Locations

University of Miami - Converge Miami
RECRUITING

Miami, Florida, 33136, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.